Information About NASH PASS for Patients
Fatty liver disease, even in its more severe form, is often a silent disease and many patients are not aware of their condition. This makes diagnosing fatty liver disease a challenge. Effectively treating the condition is also a challenge, as there are currently no FDA-approved medicines available to treat fatty liver disease. The good news is that there are many ongoing clinical trials for new therapeutics, which may provide opportunities for patients to access emerging innovative treatments and contribute to research to prevent and treat liver disease.
NASH PASS is a unique program that brings the clinical trial to your healthcare provider’s location so that patients at risk of developing fatty liver disease can obtain a diagnostic screening and learn about clinical trial opportunities in the comfort and convenience of their existing physician’s office. For information about locations that offer the NASH PASS screening program, please contact email@example.com.
Am I at Risk for Fatty Liver Disease?
¿Es Elevado Mi Riesgo de Presentar la Enfermedad de Hígado Graso?
Am I at High Risk of Developing Fatty Liver Disease?
Contact firstname.lastname@example.org for Information
on Locations That Offer the NASH PASS Screening Program
NASH PASS is a program created and managed by ProSciento, Inc., a leading clinical research organization widely recognized for nearly two decades of expertise in clinical trials for NASH, diabetes, and obesity, and contributions to the development of many life-improving, FDA-approved drugs and devices for metabolic diseases.